17212 Federal Register / Vol. 78, No. 54 / Wednesday, March 20, 2013 / Notices 

(FSAs) or Health Savings Accounts 

(HSAs). Yes/No/Don’t Know 

The MEPS Definitions form—MEPS– 

20(D)—will also be updated with new 

definitions for terms used in these new 

questions (and the deletion of terms 

used only in the deleted questions). 

There are no changes to the 2013 

MEPS–IC survey estimates of cost and 

hour burdens due to these proposed 

question changes. The response rate for 

the MEPS–IC survey also is not 

expected to change due to these 

proposed changes. 

The MEPS–IC is conducted pursuant 

to AHRQ’s statutory authority to 

conduct surveys to collect data on the 

cost, use and quality of health care, 

including the types and costs of private 

health insurance. 42 U.S.C. 299b–2(a). 

Method of Collection 

There are no changes to the current 

data collection methods. 

Estimated Annual Respondent Burden 

There are no changes to the current 

burden estimates. 

Estimated Annual Costs to the Federal 

Government 

There are no changes to the current 

cost estimates. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: March 4, 2013. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2013–06217 Filed 3–19–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From 

QAISys, Inc. 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of delisting. 

SUMMARY: The Patient Safety and 

Quality Improvement Act of 2005 

(Patient Safety Act), Public Law 109–41, 

42 U.S.C. 299b–21— b–26, provides for 

the formation of Patient Safety 

Organizations (PSOs), which collect, 

aggregate, and analyze confidential 

information regarding the quality and 

safety of health care delivery. The 

Patient Safety and Quality Improvement 

Final Rule (Patient Safety Rule), 42 CFR 

part 3, authorizes AHRQ, on behalf of 

the Secretary of HHS, to list as a PSO 

an entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found no longer to 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule, or 

when a PSO chooses to voluntarily 

relinquish its status as a PSO for any 

reason. AHRQ has accepted a 

notification of voluntary relinquishment 

from QAISys, Inc. of its status as a PSO, 

and has delisted the PSO accordingly. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on January 31, 2013. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule (PDF file, 450 KB. PDF Help) 

relating to the listing and operation of 

PSOs. The Patient Safety Rule 

authorizes AHRQ to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ if 

it is found no longer to meet the 

requirements of the Patient Safety Act 

and Patient Safety Rule, or when a PSO 

chooses to voluntarily relinquish its 

status as a PSO for any reason. Section 

3.108(d) of the Patient Safety Rule 

requires AHRQ to provide public notice 

when it removes an organization from 

the list of federally approved PSOs. 

AHRQ has accepted a notification 

from QAISys, Inc., PSO number P0046, 

to voluntarily relinquish its status as a 

PSO. Accordingly, QAISys, Inc. was 

delisted effective at 12:00 Midnight ET 

(2400) on January 31, 2013. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: March 4, 2013. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2013–06215 Filed 3–19–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From 

Universal Safety Solution PSO 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of delisting. 

SUMMARY: The Patient Safety and 

Quality Improvement Act of 2005 

(Patient Safety Act), Public Law 109–41, 

42 U.S.C. 299b–21—b–26, provides for 

the formation of Patient Safety 

Organizations (PSOs), which collect, 

aggregate, and analyze confidential 

information regarding the quality and 

safety of health care delivery. The 

Patient Safety and Quality Improvement 

Final Rule (Patient Safety Rule), 42 CFR 

part 3, authorizes AHRQ, on behalf of 

the Secretary of HHS, to list as a PSO 

an entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found no longer to 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule, or 

when a PSO chooses to voluntarily 


srobinson on DSK4SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 54 / Wednesday, March 20, 2013 / Notices 17213 

relinquish its status as a PSO for any 

reason. AHRQ has accepted a 

notification of voluntary relinquishment 

from Universal Safety Solution PSO of 

its status as a PSO, and has delisted the 

PSO accordingly. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on February 1, 2013. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule (PDF file, 450 KB. PDF Help) 

relating to the listing and operation of 

PSOs. The Patient Safety Rule 

authorizes AHRQ to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ if 

it is found no longer to meet the 

requirements of the Patient Safety Act 

and Patient Safety Rule, or when a PSO 

chooses to voluntarily relinquish its 

status as a PSO for any reason. Section 

3.108(d) of the Patient Safety Rule 

requires AHRQ to provide public notice 

when it removes an organization from 

the list of federally approved PSOs. 

AHRQ has accepted a notification 

from Universal Safety Solution PSO, 

PSO number P0104, a component entity 

of Universal Safety Solution, LLC, to 

voluntarily relinquish its status as a 

PSO. Accordingly, Universal Safety 

Solution PSO was delisted effective at 

12:00 Midnight ET (2400) on February 

1, 2013. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: March 4, 2013. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2013–06216 Filed 3–19–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[ATSDR–278] 

Agency for Toxic Substances and 

Disease Registry Availability of Final 

Toxicological Profile 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: This notice announces the 

availability of the final Toxicological 

Profile for Uranium prepared by 

ATSDR. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Delores Grant, Division of Toxicology 

and Human Health Sciences, Agency for 

Toxic Substances and Disease Registry, 

Mailstop F–57, 1600 Clifton Road NE., 

Atlanta, Georgia 30333; telephone 

number (800) 232–4636 or (770) 488– 

3351. Electronic access to this document 

is available at the ATSDR Web site: 

www.atsdr.cdc.gov/toxprofiles/ 

index.asp. 

SUPPLEMENTARY INFORMATION: The 

Superfund Amendments and 

Reauthorization Act of 1986 (SARA) 

(42 U.S.C. 9601 et seq.) amended the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA or Superfund) 

(42 U.S.C. 9601 et seq.) by establishing 

certain requirements for ATSDR and the 

U.S. Environmental Protection Agency 

(EPA) with regard to hazardous 

substances that are most commonly 

found at facilities on the CERCLA 

National Priorities List (NPL). Among 

these statutory requirements is a 

mandate for the Administrator of 

ATSDR to prepare toxicological profiles 

for each substance included on the 

priority list of hazardous substances 

(also called the Substance Priority List). 

This list identifies 275 hazardous 

substances that ATSDR (in cooperation 

with EPA) has determined pose the 

most significant potential threat to 

human health. The availability of the 

revised list of the 275 priority 

substances was announced in the 

Federal Register on November 3rd, 2011 

(76 FR 68193) and is available at 

www.atsdr.cdc.gov/spl. In addition, 

ATSDR has the authority to prepare 

toxicological profiles for substances not 

found at sites on the National Priorities 

List, in an effort to ‘‘* * * establish and 

maintain inventory of literature, 

research, and studies on the health 

effects of toxic substances’’ under 

CERCLA Section 104(i)(1)(B), to respond 

to requests for consultation under 

section 104(i)(4), and as otherwise 

necessary to support the site-specific 

response actions conducted by ATSDR. 

Notice of the availability of this 

toxicological profile in draft form for 

public review and comment was 

published in the Federal Register on 

April 27, 2011 (76 FR 23600), with 

notice of a 90-day public comment 

period, starting from the actual release 

date. Following the close of the 

comment period, chemical-specific 

comments were addressed, and, where 

appropriate, changes were incorporated 

into the profile. The public comments 

and other data submitted in response to 

the Federal Register notices bear the 

docket control number CDC–2001–005. 

This material is available for public 

inspection at ATSDR. 

Availability 

This notice announces the availability 

of the Toxicological Profile for Uranium 

prepared by ATSDR. The Toxicological 

Profile for Uranium will be made 

available to the public on or about 

March 5, 2013 at the ATSDR Web site: 

www.atsdr.cdc.gov/toxprofiles/ 

index.asp. 

This final profile is also available 

through the U.S. Department of 

Commerce, National Technical 

Information Service (NTIS), 5285 Port 

Royal Road, Springfield, Virginia 22161, 

telephone 1–800–553–6847 for a fee as 

determined by NTIS. 

Dated: March 13, 2013. 

Ken Rose, 

Director, Office of Policy, Planning and 

Evaluation, National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. 2013–06377 Filed 3–19–13; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: National Directory of New 

Hires. 

OMB No.: 0970–0166. 

Description: The National Directory of 

New Hires (NDNH), an automated 

directory maintained by the Federal 


srobinson on DSK4SPTVN1PROD with NOTICES